Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ciardiello

Showing results (151-160 of 188) with videos related to

Pageof 19
Sort By:
International Journal of Cancer|January 3, 1996
Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissuesL Panico, A D'Antonio, G Salvatore, et al.
Current Oncology (Toronto, Ont.)|August 2, 2013
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancerF Morgillo, F De Vita, G Antoniol, et al.
British Journal of Cancer|May 10, 2012
Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cellsT Troiani, L Vecchione, E Martinelli, et al.
Gastroenterology Research and Practice|July 10, 2018
Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score AnalysisJ Ventriglia, A Petrillo, M Huerta Alváro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2016
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in ItalyF Perrone, C Jommi, M Di Maio, et al.
ESMO Open|June 2, 2022
Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRCS Kopetz, A Grothey, E Van Cutsem, et al.
Breast (Edinburgh, Scotland)|August 14, 2018
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugsM Orditura, C M Della Corte, A Diana, et al.
Cancer Investigation|March 5, 2008
Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancerF Iovino, F Ferraraccio, M Orditura, et al.
British Journal of Cancer|April 28, 2005
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patientsF De Vita, M Orditura, E Matano, et al.
British Journal of Cancer|January 20, 2011
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancerF De Vita, M Orditura, E Martinelli, et al.
Pageof 19

Showing results (151-160 of 188) with videos related to

Sort By:
Pageof 19
International Journal of Cancer|January 3, 1996
Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissuesL Panico, A D'Antonio, G Salvatore, et al.
Current Oncology (Toronto, Ont.)|August 2, 2013
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancerF Morgillo, F De Vita, G Antoniol, et al.
British Journal of Cancer|May 10, 2012
Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cellsT Troiani, L Vecchione, E Martinelli, et al.
Gastroenterology Research and Practice|July 10, 2018
Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score AnalysisJ Ventriglia, A Petrillo, M Huerta Alváro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2016
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in ItalyF Perrone, C Jommi, M Di Maio, et al.
ESMO Open|June 2, 2022
Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRCS Kopetz, A Grothey, E Van Cutsem, et al.
Breast (Edinburgh, Scotland)|August 14, 2018
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugsM Orditura, C M Della Corte, A Diana, et al.
Cancer Investigation|March 5, 2008
Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancerF Iovino, F Ferraraccio, M Orditura, et al.
British Journal of Cancer|April 28, 2005
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patientsF De Vita, M Orditura, E Matano, et al.
British Journal of Cancer|January 20, 2011
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancerF De Vita, M Orditura, E Martinelli, et al.
Pageof 19